247 related articles for article (PubMed ID: 26400571)
1. Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis.
Springer J; Lackner M; Nachbaur D; Girschikofsky M; Risslegger B; Mutschlechner W; Fritz J; Heinz WJ; Einsele H; Ullmann AJ; Löffler J; Lass-Flörl C
Clin Microbiol Infect; 2016 Jan; 22(1):80-86. PubMed ID: 26400571
[TBL] [Abstract][Full Text] [Related]
2. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.
Reinwald M; Hummel M; Kovalevskaya E; Spiess B; Heinz WJ; Vehreschild JJ; Schultheis B; Krause SW; Claus B; Suedhoff T; Schwerdtfeger R; Reuter S; Kiehl MG; Hofmann WK; Buchheidt D
J Antimicrob Chemother; 2012 Sep; 67(9):2260-7. PubMed ID: 22740590
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Aspergillus-specific PCR as a screening method for invasive aspergillosis in paediatric cancer patients and allogeneic haematopoietic stem cell recipients with suspected infections.
Reinwald M; Konietzka CA; Kolve H; Uhlenbrock S; Ahlke E; Hummel M; Spiess B; Hofmann WK; Buchheidt D; Groll AH
Mycoses; 2014 Sep; 57(9):537-43. PubMed ID: 24655146
[TBL] [Abstract][Full Text] [Related]
4. Potential of polymerase chain reaction and galactomannan for the diagnosis of invasive aspergillosis in patients with febrile neutropenia.
Aslan M; Oz Y; Aksit F; Akay OM
Mycoses; 2015 Jun; 58(6):343-9. PubMed ID: 25851634
[TBL] [Abstract][Full Text] [Related]
5. Aspergillus specific nested PCR from the site of infection is superior to testing concurrent blood samples in immunocompromised patients with suspected invasive aspergillosis.
Boch T; Spiess B; Heinz W; Cornely OA; Schwerdtfeger R; Hahn J; Krause SW; Duerken M; Bertz H; Reuter S; Kiehl M; Claus B; Deckert PM; Hofmann WK; Buchheidt D; Reinwald M
Mycoses; 2019 Nov; 62(11):1035-1042. PubMed ID: 31402465
[TBL] [Abstract][Full Text] [Related]
6. Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative.
White PL; Barnes RA; Springer J; Klingspor L; Cuenca-Estrella M; Morton CO; Lagrou K; Bretagne S; Melchers WJ; Mengoli C; Donnelly JP; Heinz WJ; Loeffler J;
J Clin Microbiol; 2015 Sep; 53(9):2832-7. PubMed ID: 26085618
[TBL] [Abstract][Full Text] [Related]
7. Detection of Aspergillus DNA by a nested PCR assay is able to improve the diagnosis of invasive aspergillosis in paediatric patients.
Hummel M; Spiess B; Roder J; von Komorowski G; Dürken M; Kentouche K; Laws HJ; Mörz H; Hehlmann R; Buchheidt D
J Med Microbiol; 2009 Oct; 58(Pt 10):1291-1297. PubMed ID: 19541789
[TBL] [Abstract][Full Text] [Related]
8. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.
Cruciani M; Mengoli C; Loeffler J; Donnelly P; Barnes R; Jones BL; Klingspor L; Morton O; Maertens J
Cochrane Database Syst Rev; 2015 Sep; (9):CD009551. PubMed ID: 26343815
[TBL] [Abstract][Full Text] [Related]
9. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia.
Halliday C; Hoile R; Sorrell T; James G; Yadav S; Shaw P; Bleakley M; Bradstock K; Chen S
Br J Haematol; 2006 Feb; 132(4):478-86. PubMed ID: 16412020
[TBL] [Abstract][Full Text] [Related]
10. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.
Cruciani M; Mengoli C; Loeffler J; Donnelly P; Barnes R; Jones BL; Klingspor L; Morton O; Maertens J
Cochrane Database Syst Rev; 2015 Oct; (10):CD009551. PubMed ID: 26424726
[TBL] [Abstract][Full Text] [Related]
11. Molecular detection of invasive aspergillosis in hematologic malignancies.
Badiee P; Kordbacheh P; Alborzi A; Ramzi M; Shakiba E
Infection; 2008 Dec; 36(6):580-4. PubMed ID: 18854937
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
[TBL] [Abstract][Full Text] [Related]
13. Aspergillus PCR-based investigation of fresh tissue and effusion samples in patients with suspected invasive Aspergillosis enhances diagnostic capabilities.
Reinwald M; Spiess B; Heinz WJ; Heussel CP; Bertz H; Cornely OA; Hahn J; Lehrnbecher T; Kiehl M; Laws HJ; Wolf HH; Schwerdtfeger R; Schultheis B; Burchardt A; Klein M; Dürken M; Claus B; Schlegel F; Hummel M; Hofmann WK; Buchheidt D
J Clin Microbiol; 2013 Dec; 51(12):4178-85. PubMed ID: 24108612
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies.
Florent M; Katsahian S; Vekhoff A; Levy V; Rio B; Marie JP; Bouvet A; Cornet M
J Infect Dis; 2006 Mar; 193(5):741-7. PubMed ID: 16453271
[TBL] [Abstract][Full Text] [Related]
15. Prospective Biomarker Screening for Diagnosis of Invasive Aspergillosis in High-Risk Pediatric Patients.
Loeffler J; Hafner J; Mengoli C; Wirth C; Heussel CP; Löffler C; White PL; Ullmann AJ; Michel D; Wiegering V; Wölfl M; Schlegel PG; Einsele H; Springer J; Eyrich M
J Clin Microbiol; 2017 Jan; 55(1):101-109. PubMed ID: 27795339
[TBL] [Abstract][Full Text] [Related]
16. Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance.
Suarez F; Lortholary O; Buland S; Rubio MT; Ghez D; Mahé V; Quesne G; Poirée S; Buzyn A; Varet B; Berche P; Bougnoux ME
J Clin Microbiol; 2008 Nov; 46(11):3772-7. PubMed ID: 18845828
[TBL] [Abstract][Full Text] [Related]
17. Galactomannan and Polymerase Chain Reaction-Based Screening for Invasive Aspergillosis Among High-Risk Hematology Patients: A Diagnostic Meta-analysis.
Arvanitis M; Anagnostou T; Mylonakis E
Clin Infect Dis; 2015 Oct; 61(8):1263-72. PubMed ID: 26157047
[TBL] [Abstract][Full Text] [Related]
18. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
Armenian SH; Nash KA; Kapoor N; Franklin JL; Gaynon PS; Ross LA; Hoffman JA
J Pediatr Hematol Oncol; 2009 Dec; 31(12):920-6. PubMed ID: 19855303
[TBL] [Abstract][Full Text] [Related]
19. Aspergillus PCR formidable challenges and progress.
Klingspor L; Loeffler J
Med Mycol; 2009; 47 Suppl 1():S241-7. PubMed ID: 19253138
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of Aspergillus-PCR for detection of invasive aspergillosis in immunosuppressed patients.
Lass-Flörl C; Gunsilius E; Gastl G; Freund M; Dierich MP; Petzer A
Mycoses; 2005; 48 Suppl 1():12-7. PubMed ID: 15826281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
